Screener
Agios Pharmaceuticals AGIO Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by Agios Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.
The source filing: Agios Pharmaceuticals’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 9:56 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001439222-26-000118
| (In thousands, except share and per share data) | June 30,2026 | December 31,2025 |
|---|---|---|
| Accounts receivable, net | 20,112 | 10,577 |
| Inventory | 30,152 | 32,920 |
| Contract assets | 4,104 | — |
| Prepaid expenses and other current assets | 45,724 | 44,130 |
| Total current assets | 717,668 | 942,052 |
| Marketable securities | 347,254 | 310,013 |
| Operating lease assets | 23,875 | 30,454 |
| Property and equipment, net | 9,946 | 10,775 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Agios Pharmaceuticals's prepaid & other current?
- Agios Pharmaceuticals (AGIO) reported prepaid & other current of $45.72M in Q2 2026.
- How has Agios Pharmaceuticals's prepaid & other current changed year-over-year?
- Agios Pharmaceuticals's prepaid & other current increased by 2.3% year-over-year, from $44.69M to $45.72M.
- What is the long-term trend for Agios Pharmaceuticals's prepaid & other current?
- Over 5 years (2020 to 2025), Agios Pharmaceuticals's prepaid & other current has grown at a 13.3% compound annual growth rate (CAGR), from $23.65M to $44.13M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.
Ask your AI about Agios Pharmaceuticals's prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude